comprehensive -WSS

comprehensive

author：explore 2025-09-30 12:18:52 - browse：3

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Did the public have the right to know Arthur Ashe had AIDS?

leisure time

explore

WSS

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Australia's humpback populations rebound raising hopes of marine scientists

Bird flu reported in person exposed to presumably infected cattle

Can food be medicine? And other questions about a new push

7 people shot in DC, police say

Listen: PBM conflicts, RSV vaccines, & the future of flu season

focus

comprehensive

explore

As demand for Covid shots wanes, Moderna seeks its next success

New case study details death in closely watched Alzhiemer's trial

Trump demands the U.S. pay no more for drugs than other countries … again

U.K. decision on ALS drug has neurologists, advocates up in arms

As demand for Covid shots wanes, Moderna seeks its next success

Pfizer's Covid pill remains 89% effective in final analysis, company says

Tori Bowie and the unacceptable rates of Black maternal death

Doctor appointment wait times are getting worse

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

focus

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Bird flu in dairy cattle: New measures to control spread to humans

Republican states more likely to report Covid vaccine side effects

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Multiple sclerosis has subtypes with different best treatments: study

entertainment

leisure time

explore

focus